Victory Capital Management’s iRadimed IRMD Stock Holding History

Victory Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Buy	26,082 +3	+0%	+$300	﹤0.01%	1535
2025 Q4	$2.54M	Sell	26,079 -486	-2%	-$41.7K	﹤0.01%	1523
2025 Q3	$1.89M	Buy	26,565 +5,021	+23%	+$335K	﹤0.01%	1616
2025 Q2	$1.29M	Buy	21,544 +16,944	+368%	+$929K	﹤0.01%	1737
2025 Q1	$241K	Buy	+4,600	New	+$258K	﹤0.01%	2179
2021 Q3	–	Sell	-5,452	Closed	-$160K	–	2807
2021 Q2	$160K	Buy	5,452 +222	+4%	+$6.12K	﹤0.01%	2553
2021 Q1	$135K	Buy	+5,230	New	+$125K	﹤0.01%	2567
2020 Q2	–	Sell	-8,584	Closed	-$184K	–	2874
2020 Q1	$184K	Buy	8,584 +3,853	+81%	+$91.8K	﹤0.01%	2354
2019 Q4	$111K	Buy	4,731 +1,268	+37%	+$29.6K	﹤0.01%	2507
2019 Q3	$73K	Buy	3,463 +712	+26%	+$14.5K	﹤0.01%	2543
2019 Q2	$56K	Sell	2,751 -4,780	-63%	-$113K	﹤0.01%	1719
2019 Q1	$212K	Buy	+7,531	New	+$197K	﹤0.01%	1552

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's IRMD Position: Q1 2026 in Review

Victory Capital Management increased its iRadimed (IRMD) stake by 0.01% in Q1 2026, buying an estimated $300 and bringing the position to 26,082 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Victory Capital Management first reported a position in IRMD in Q1 2019 and has held it in 12 quarters since. The position peaked at $2.54M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Victory Capital Management held 26,082 shares of iRadimed worth $2.51M as of Q1 2026.
Victory Capital Management bought 3 iRadimed shares in Q1 2026, an estimated $300.
iRadimed made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1535 holding.
Victory Capital Management first reported a position in iRadimed in Q1 2019 and has held it in 12 quarters since.
Victory Capital Management's iRadimed position peaked at $2.54M in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.